Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Cematrix ( (TSE:CEMX) ).
CEMATRIX Corporation announced it will release its second quarter financial results for 2025 on August 6, followed by a webinar on August 7 to discuss the results and provide a corporate update. This announcement is significant as it provides stakeholders with insights into the company’s financial health and operational progress, potentially impacting its market positioning and investor confidence.
The most recent analyst rating on (TSE:CEMX) stock is a Buy with a C$0.35 price target. To see the full list of analyst forecasts on Cematrix stock, see the TSE:CEMX Stock Forecast page.
Spark’s Take on TSE:CEMX Stock
According to Spark, TipRanks’ AI Analyst, TSE:CEMX is a Neutral.
Cematrix’s overall stock score is primarily driven by its strong corporate events and positive technical indicators. While the balance sheet shows strength, challenges in profitability and valuation weigh down the score. The stock is buoyed by recent contract wins, suggesting potential for future growth despite current financial struggles.
To see Spark’s full report on TSE:CEMX stock, click here.
More about Cematrix
CEMATRIX Corporation is a specialty construction contractor that produces cellular concrete solutions on site. The company is a leading manufacturer and supplier of cellular concrete in North America, offering innovative solutions for geotechnical construction challenges. Applications for their products include lightweight engineered fill, MSE & retaining wall fill, and underwater fills, among others. CEMATRIX operates through its subsidiaries, CEMATRIX (Canada) Inc., MixOnSite USA Inc., and Pacific International Grout Company.
Average Trading Volume: 149,863
Technical Sentiment Signal: Buy
Current Market Cap: C$47.31M
Find detailed analytics on CEMX stock on TipRanks’ Stock Analysis page.